Our Team

Cultivating global advancement in male fertility

Leadership Team

Michael V. Novinski

Co-Founder and Chief Executive Officer

Michael Novinski is a co-founder and the Chief Executive Officer for Androvia LifeSciences. An experienced leader in the pharmaceutical and biotechnology fields with a special focus on reproductive health, Michael has more than 35 years of life sciences experience. He held the position of president of Organon BioSciences USA, a biopharmaceutical company focused on female reproductive health acquired by Schering-Plough Corporation and served as Executive VP, Operations and Marketing for NV Organon while residing in Europe. He has commercialized more than 15 products through FDA approval and an additional 10 on a worldwide basis.

Michael served on the Board of Directors of the Pharmaceutical Research and Manufacturers of America (PhRMA) for four years, and is the author of ALL for one and ONE for all, released by Tate Publishing in May 2013. He has several patents for both innovative pharmaceutical formulations and packaging, and has been recognized in Business Week, Drug Delivery Technology, and BioWorld, among other news outlets, and a contributing thought leader to Life Science Leader.

Alexander J. Travis, VMD, PHD

Co-Founder and Chief Scientific Officer

Dr. Alex Travis is the co-founder and Chief Scientific Officer for Androvia LifeSciences. An associate professor at Cornell University, Dr. Travis is a world leader in the research of capacitation and directs a laboratory focused on the investigation of sperm, fertilization, and new technologies of assisted reproduction. His research was the first to link patterns of GM1 localization with capacitation status, identifying it as a biomarker for sperm fertilizing ability. This laid the groundwork for Androvia’s laboratory-developed test, the Cap-Score™ Sperm Function Test. Dr. Travis is the corresponding author on Androvia’s publication, “Localization patterns of the ganglioside GM1 in human sperm are indicative of male fertility and independent of traditional semen measures” and a co-author on, “Validation of a laboratory developed test of human sperm capacitation” (both published in Molecular Reproduction and Development 2017). Dr. Travis is a frequent speaker at major scientific conferences including the American Society of Andrology, the American Urological Association, and the Gordon Conference on Fertilization. He has also been the author of over 50 scientific publications, and numerous scientific abstracts and poster presentations on sperm function.

Dr. Travis graduated from Princeton University magna cum laude. He received a diploma in Reproductive Science from Monash University under a Rotary Graduate Fellowship. Dr. Travis received both his VMD and PhD at the University of Pennsylvania, from which he graduated summa cum laude with the Leonard Pearson Prize, the veterinary school’s highest honor. Among other awards, he was the first veterinarian to ever receive a Pioneer Award from the National Institutes of Health and he has received the State University of New York Chancellor’s Award for Excellence in Scholarship and Creative Activities.

Clinical Advisory Team

Gianpiero D. Palermo

Dr. Gianpiero Palermo on the Cap-Score™ Sperm Function Test…

“For decades, clinicians and couples have needed a test of sperm function, to complement semen analysis and provide understanding of their fertility. This information can help them decide together on the form of assisted reproduction that is right for that couple at that time. The Cap-Score ™ Sperm Function Test is the first practical assay that provides this important window into male fertility.”

Dr. Palermo is professor of reproductive medicine at Weill Cornell Medical College, and Director of Assisted Fertilization and Andrology at Cornell’s Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine. In 1992, Dr. Palermo developed the revolutionary fertility procedure known as “intracytoplasmic sperm injection” (ICSI), in which a single sperm is directly injected into a mature egg. This technique has provided over 100,000 couples world-wide with the means to overcome multiple types of male factor infertility, and successfully have children. Dr. Palermo and his laboratory performed the first clinical trial on use of GM1 localization patterns to assess human male fertility, independently before Androvia was formed. He found that specific patterns tracked strongly with male fertility, with men with high Cap-Scores having very good pregnancy rates by natural conception or within three or fewer cycles of intrauterine insemination, versus men who scored below that threshold, who had very poor chances of success. Dr. Palermo is a co-author on “Localization patterns of the ganglioside GM1 in human sperm are indicative of male fertility and independent of traditional semen measures” (Molecular Reproduction and Development 2017), in which these data are published.

Dr. Palermo received his MD from the University of Bari School of Medicine, his MSc at Brussels Free University and his PhD from Monash University. His groundbreaking discovery of ICSI and his continued clinical and scientific contributions have earned him multiple awards including the Serono Prize for Medical Research, the Barbara Eck Menning Founder’s Award, the Jacob Heskel Gabbay Award in Biotechnology and Medicine, and the Russian Crystal Tube Award. In 2014, he was named Embryologist of the Year.  He has published well over 100 peer-reviewed papers and given over 300 scientific and clinical presentations.

Jay S. Schinfeld

Dr. Schinfeld on the Cap-Score™ Sperm Function Test…

“The need to further investigate patients with unexplained infertility and failed intrauterine insemination (IUI) has made a giant leap forward by determining sperm function (capacitation or activation). Men who fail this test need to consider IVF with sperm injection(ICSI), while others can try a few cycles of IUI if they prefer based on age and insurance. The Cap-Score™ Sperm Function Test saves the patient time, effort, money and emotion. We are happy to offer this test to our couples.”

Dr. Schinfeld is the Founder of Abington Reproductive Medicine, the first clinic in Pennsylvania to offer the Cap-Score™ Sperm Function Test, and the Founding Director of the Division of Reproductive Endocrinology and Infertility at Abington Memorial Hospital in Pennsylvania. Dr. Schinfeld has more than 40 years of experience in the field of infertility and is highly revered as Clinical Professor at Jefferson Medical College and Adjunct Professor OB/GYN at Temple University School of Medicine. Among Dr. Schinfeld’s many areas of interest and expertise are preimplantation genetics, in vitro fertilization and intracytoplasmic sperm injection.

Eric K. Seaman

Dr. Eric Seaman on the Cap-Score™ Sperm Function Test…

Androvia’s preliminary research has already validated the ability of the test to discriminate between fertile and infertile populations of men. More accurate testing is the first step towards more effective treatments. The Cap-Score™ Sperm Function Test can prove to be a game changer for physicians who treat infertility and for their patients.”

Founder and Director of the Center for Vasectomy, Vasectomy Reversal and Male Infertility of New Jersey, one of the first clinics to offer the Cap-Score™ Sperm Function Test. Dr. Seaman has specialized in male fertility for more than 20 years and is a board-certified urologist and experienced micro-surgeon. He is passionately focused on male reproductive medicine, specializing in microsurgical techniques including vasectomy reversal and surgical sperm retrieval. Dr. Seaman has been repeatedly recognized as one of New Jersey’s “Top Doctors” by New Jersey Monthly Magazine.

Dr. Seaman’s practice was involved with some of Androvia’s initial research and aided in their ability to define Cap-Score results for a normal fertile population versus an infertile population. Dr. Seaman is a co-author on Androvia’s landmark publication, “Localization patterns of the ganglioside GM1 in human sperm are indicative of male fertility and independent of traditional semen measures” (Molecular Reproduction and Development 2017). He is also a listed author for several scientific abstracts and poster presentations on sperm function presented at various conferences in 2016 including the American Society of Andrology (ASA), the American Urological Association (AUA) and the American Society for Reproductive Medicine.

Fady I. Sharara

Dr. Fady Sharara on the Cap-Score™ Sperm Function Test…

“The Cap-Score™ Sperm Function Test represents a new frontier in semen analysis and allows us to personalize treatment for couples from the very beginning.”

Dr. Sharara is the Founder and Medical Director of the Virginia Center for Reproductive Medicine, one of the first clinics to offer the Cap-Score™ Sperm Function Test.  Currently, Dr. Sharara holds the position of Clinical Professor OB/GYN at George Washington University in Washington, D.C. Dr. Sharara has published more than 80 scientific papers addressing issues of infertility. Dr. Sharara is also a reviewer for several peer reviewed journals including Fertility & Sterility and Human Reproduction and was named to the editorial board of the Middle East Fertility Society Journal. In 2004, Dr. Sharara was recognized as International Scientist of the Year. Dr. Sharara is a member of several fertility societies, serving on the American Society for Reproductive Medicine (ASRM) Practice Committee from 2007 to 2013. Additionally, Dr. Sharara has served on the Society of Assisted Reproductive Technology (SART) Practice Committee since 2007, a six-member committee responsible for updating protocols for the latest Assisted Reproductive Technologies.

Clinical and Research Team

Bryan Kloos

Laboratory Director
Technical Supervisor

Bryan Kloos joined Androvia LifeSciences in February of 2017 as the Laboratory Director and Technical Supervisor. Bryan is board certified by the American Board of Bioanalysts as a High Complexity Laboratory Director (HCLD). Bryan is experienced working with the requirements and regulations associated with directing CAP, CLIA and FDA laboratories including accreditation, certification and compliance.

Bryan has been working in the field of fertility and assisted reproductive technologies for over ten years. Currently, Dr. Kloos serves as the Laboratory Director for two high complexity laboratories, Global Fertility & Genetics and Park Avenue Fertility & Reproductive Medicine. In addition, Bryan serves as President & CEO of ART Laboratory Logistics.

In 2007, Dr. Kloos received his PhD in Cellular and Molecular Biology from the Mount Sinai School of Medicine of New York University.

Romeo Mendoza

Laboratory Supervisor

Romeo Mendoza joined Androvia LifeSciences in September of 2016 as the Laboratory Supervisor. He is a board-certified Medical Technologist with over 27 years of laboratory experience at board level for military, private and public laboratories.

Prior to joining Androvia, Romeo spent 24 years in the US Navy working as a laboratory chief in different military medical facilities in the US and abroad. Romeo received his board certification from the American Medical Technologists (AMT) and obtained his New York State Laboratory Technologist license. He served as a laboratory supervisor at Idant Laboratories where he managed the daily operations of both the Semen Bank and Blood Bank sections of the laboratory. Romeo also worked for the New York City Department of Health Public Health Laboratory division as an Associate Laboratory Microbiologist.

His military decorations include the Navy and Marine Corps Commendation Medal, Navy and Marine Corps Achievement Medal, Good Conduct Medal and Military Volunteer Medal and various campaign and unit awards culminating to years of outstanding leadership as a laboratory chief.

Melissa Moody

QA/QC Manager
Research Scientist

Melissa Moody joined Androvia LifeSciences in February of 2015 as a Research Scientist. Currently, Melissa serves as the Quality Assurance/Quality Control Manager and is responsible for overseeing the analysis of sperm images, procuring the images for analysis, and methods and processes associated with the company’s proprietary technology. Melissa is the first author of “Validation of a laboratory developed test of human sperm capacitation” and a co-author of “Localization patterns of the ganglioside GM1 in human sperm are indicative of male fertility and independent of traditional semen measures” (Molecular Reproduction and Development 2017). She is also a listed author for several scientific abstracts and poster presentations on sperm function presented at various conferences in 2016 including the American Society of Andrology (ASA), the American Urological Association (AUA) and the American Society for Reproductive Medicine.

In 2011, Melissa graduated from Pennsylvania State University and received her BS in Animal Sciences. In 2014, Melissa received her MS in Molecular Biology from Lehigh University.

Alana Simpson

Clinical Training Manager
Research Scientist

Alana Simpson joined Androvia LifeSciences in June of 2015 as a Research Scientist. Currently, Alana serves as the Clinical Training Manager and is responsible for overseeing the training of commercial clinics offering the Cap-Score™ Sperm Function Test.  Alana is a co-author on both of Androvia’s publications, “Localization patterns of the ganglioside GM1 in human sperm are indicative of male fertility and independent of traditional semen measures” and “Validation of a laboratory developed test of human sperm capacitation” (Molecular Reproduction and Development 2017). She is also a listed author for several scientific abstracts and poster presentations on sperm function presented at various conferences in 2016 including the American Society of Andrology (ASA), the American Urological Association (AUA) and the American Society for Reproductive Medicine. Alana is also responsible for selected commercial processes within Androvia LifeSciences.

In 2012, Alana graduated from Montclair State University and received her BS in Biology.

Chuck Ostermeier

Senior Research Scientist

Charles Ostermeier, PhD (Chuck) joined Androvia LifeSciences in April of 2015 as Senior Research Scientist. Chuck is a co-author on “Localization patterns of the ganglioside GM1 in human sperm are indicative of male fertility and independent of traditional semen measures” and corresponding author on the second publication, “Validation of a laboratory developed test of human sperm capacitation” (Molecular Reproduction and Development 2017). He is also a listed author for several scientific abstracts and poster presentations on sperm function presented at various conferences in 2016 including the American Society of Andrology (ASA), the American Urological Association (AUA) and the American Society for Reproductive Medicine. Over the course of his career, Chuck has more than 30 peer reviewed publications, book chapters and patents.

In 2000, Dr. Ostermeier received his PhD from the University of Wisconsin-Madison where he developed objective mathematical measures of sperm morphology and investigated their relation to fertility.  While completing his Post-Doctoral Fellowship at Wayne State University, Chuck investigated the regulation of spermatogenic gene expression.  Chuck grew his experience in genetics and assisted reproductive technology during his tenure at The Jackson Laboratory.

Cristina Cardona

Research Scientist

Cristina Cardona, PhD, joined Androvia LifeSciences in June of 2015 as a Research Scientist. Cristina is the first author of “Localization patterns of the ganglioside GM1 in human sperm are indicative of male fertility and independent of traditional semen measures” and a co-author of “Validation of a laboratory developed test of human sperm capacitation” (Molecular Reproduction and Development 2017). She is also a listed author for several scientific abstracts and poster presentations on sperm function presented at various conferences in 2016 including the American Society of Andrology (ASA), the American Urological Association (AUA) and the American Society for Reproductive Medicine.

In 2014, Dr. Cardona received her PhD in cell and developmental biology from Rutgers University, where she studied meiotic recombination in oocytes.